If you have hereditary ATTR amyloidosis, there's a 50% chance of passing it to your children.
The HSE have reversed a decision not to reimburse people for a drug for those with a rare condition that causes nerve damage.
Hereditary ATTR amyloidosis, has a specific Irish variant and can be passed on genetically.
Amvuttra is a new treatment that would only need to be administered 4 times a year, rather than the 17 times required currently.
Last year, the Health Service decided the drug would not be reimbursed, however, that decision has been reversed subject to a managed access protocol.
Fianna Fáil Longford Westmeath TD, Joe Flaherty says it's an important move:
Midlands Gardaí Appeal For Witnesses To Fatal Crash
Midlands Security & Defence Analyst Says Hoax Bomb Threats Aimed To Intimidate
Almost €446,000 Allocated To Midlands Community Centres And Clubhouses
Midlands Family Takes On Ireland’s Fittest Family Challenge
5K Fundraiser To Support Motor Neurone Disease Association Takes Place In Westmeath
No Slowing Down With Age As Westmeath Bowlers Shine At 14th Annual National Bowls Competition
Woman Appears In Court Over €280k Cannabis Seizure In Midlands